The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
916
Systemic Antifungal Drugs
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Systemic Antifungal Drugs
The incidence of serious fungal infections continues to increase, particularly in patiens who have AIDS or taking immunosuppressive drugs. The drugs of choice for treatment of these infection are listed in the table on page 18
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Systemic Antifungal Drugs
Article code: 916b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.